R. Lor Randall
University of California Davis Medical Center(US)UC Davis Health(US)University of California, Davis(US)Intuit (United States)(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Management of metastatic bone disease, Vascular Tumors and Angiosarcomas, Cancer Diagnosis and Treatment
Most-Cited Works
- → Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes(2011)997 cited
- → Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology(2018)724 cited
- → Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort(2019)709 cited
- → Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial(2016)517 cited
- → Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial(2015)416 cited